{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-036749","form_type":"8-K","ticker":"ARDX","cik":"0001437402","company_name":"ARDELYX, INC.","filed_at":"2024-08-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.063569+00:00","generated_at":"2026-05-31T10:00:08.375929+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ardelyx enters commercial supply agreement with Catalent for IBSRELA through 2028","bullets":["Agreement covers tableting, testing, release and bulk packaging of IBSRELA (tenapanor HCl) at Catalent's Winchester, KY facility.","Initial term through Dec 31, 2028, with automatic renewal for two-year terms thereafter.","Minimum purchase commitment: minimum number of batches per contract year.","Unit pricing adjusted annually starting Jan 1, 2025, based on producer price index.","Either party can terminate for material breach after cure period."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-036749","json":"https://secwatch.observer/filing/0001628280-24-036749.json","markdown":"https://secwatch.observer/filing/0001628280-24-036749.md","text":"https://secwatch.observer/filing/0001628280-24-036749.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024036749/0001628280-24-036749-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1437402/000162828024036749/ardx-20240807.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:00:08.375929+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}